Advertisement
Screener

REVVITY, INC (RVTY) Goodwill, Foreign Currency Translation Gain (Loss)

2.3 / 5 stars · 54/120 Roast Me

REVVITY, INC Goodwill, Foreign Currency Translation Gain (Loss)

REVVITY, INC (RVTY) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$37.51 million for the 6-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.

Financial Statements › Income Statement › Other Income

us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-11

  • REVVITY, INC goodwill, foreign currency translation gain (loss) for the quarter ending 2026-07-05 was -$2.73M, a 102.63% decline year-over-year.
  • REVVITY, INC goodwill, foreign currency translation gain (loss) for the quarter ending 2026-04-05 was -$34.78M, a 172.65% decline year-over-year.
  • REVVITY, INC goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-28 was $12.86M.
  • REVVITY, INC goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-28 was -$14.36M, a 123.27% decline year-over-year.
  • REVVITY, INC goodwill, foreign currency translation gain (loss) for fiscal 2025 was $149.87M.
  • REVVITY, INC goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$69.93M, a 235.05% decline from fiscal 2023.
  • REVVITY, INC goodwill, foreign currency translation gain (loss) for fiscal 2023 was $51.78M.
  • REVVITY, INC goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$139.88M.
Period endGoodwill, Foreign Currency Translation Gain (Loss) 3 monthGoodwill, Foreign Currency Translation Gain (Loss) 6 monthGoodwill, Foreign Currency Translation Gain (Loss) 9 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed
2026-07-05-$2.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$37.51M
10-Q · filed 2026-08-11
-$24.64M
derived: sum of 3 quarters · filed 2026-08-11
-$39.00M
derived: sum of 4 quarters · filed 2026-08-11
2026-04-05-$34.78M
10-Q · filed 2026-05-12
-$21.92M
derived: sum of 2 quarters · filed 2026-05-12
-$36.27M
derived: sum of 3 quarters · filed 2026-05-12
$67.23M
derived: sum of 4 quarters · filed 2026-05-12
2025-12-28$12.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.50M
derived: sum of 2 quarters · filed 2026-02-24
$102.00M
derived: sum of 3 quarters · filed 2026-02-24
$149.87M
10-K · filed 2026-02-24
2025-09-28-$14.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$89.14M
derived: sum of 2 quarters · filed 2025-11-04
$137.01M
10-Q · filed 2025-11-04
$41.97M
derived: sum of 4 quarters · filed 2026-02-24
2025-06-29$103.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$151.37M
10-Q · filed 2025-08-05
$56.33M
derived: sum of 3 quarters · filed 2026-02-24
$118.02M
derived: sum of 4 quarters · filed 2026-02-24
2025-03-30$47.87M
10-Q · filed 2025-05-06
-$47.17M
derived: sum of 2 quarters · filed 2026-02-24
$14.52M
derived: sum of 3 quarters · filed 2026-02-24
$7.59M
derived: sum of 4 quarters · filed 2026-02-24
2024-12-29-$95.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$33.35M
derived: sum of 2 quarters · filed 2026-02-24
-$40.28M
derived: sum of 3 quarters · filed 2026-02-24
-$69.93M
10-K · filed 2026-02-24
2024-09-29$61.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$54.76M
derived: sum of 2 quarters · filed 2024-11-06
$25.11M
10-Q · filed 2024-11-06
$88.52M
derived: sum of 4 quarters · filed 2025-02-25
2024-06-30-$6.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$36.58M
10-Q · filed 2024-08-06
$26.83M
derived: sum of 3 quarters · filed 2025-02-25
-$21.45M
derived: sum of 4 quarters · filed 2025-02-25
2024-03-31-$29.65M
10-Q · filed 2024-05-07
$33.76M
derived: sum of 2 quarters · filed 2025-02-25
-$14.52M
derived: sum of 3 quarters · filed 2025-02-25
-$2.06M
derived: sum of 4 quarters · filed 2025-02-25
2023-12-31$63.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$15.13M
derived: sum of 2 quarters · filed 2025-02-25
$27.59M
derived: sum of 3 quarters · filed 2025-02-25
$51.78M
10-K · filed 2025-02-25
2023-10-01-$48.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$35.82M
derived: sum of 2 quarters · filed 2023-11-07
-$11.63M
10-Q · filed 2023-11-07
$99.07M
derived: sum of 4 quarters · filed 2024-02-27
2023-07-02$12.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$36.65M
10-Q · filed 2023-08-09
$147.35M
derived: sum of 3 quarters · filed 2024-02-27
$68.97M
derived: sum of 4 quarters · filed 2024-02-27
2023-04-02$24.19M
10-Q · filed 2023-05-12
$134.89M
derived: sum of 2 quarters · filed 2024-02-27
$56.50M
derived: sum of 3 quarters · filed 2024-02-27
-$63.77M
derived: sum of 4 quarters · filed 2024-02-27
2023-01-01$110.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$32.32M
derived: sum of 2 quarters · filed 2024-02-27
-$87.96M
derived: sum of 3 quarters · filed 2024-02-27
-$139.88M
10-K · filed 2024-02-27
2022-10-02-$78.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$198.66M
derived: sum of 2 quarters · filed 2022-11-14
-$250.59M
10-Q · filed 2022-11-14
-$255.20M
derived: sum of 4 quarters · filed 2023-03-01
2022-07-03-$120.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$172.20M
10-Q · filed 2022-08-09
-$176.82M
derived: sum of 3 quarters · filed 2023-03-01
-$209.70M
derived: sum of 4 quarters · filed 2023-03-01
2022-04-03-$51.93M
10-Q · filed 2022-05-10
-$56.54M
derived: sum of 2 quarters · filed 2023-03-01
-$89.43M
derived: sum of 3 quarters · filed 2023-03-01
-$81.00M
derived: sum of 4 quarters · filed 2023-03-01
2022-01-02-$4.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$37.50M
derived: sum of 2 quarters · filed 2023-03-01
-$29.07M
derived: sum of 3 quarters · filed 2023-03-01
-$74.46M
10-K · filed 2023-03-01
-$92.52M
10-K · filed 2022-03-03
2021-10-03-$32.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$24.46M
derived: sum of 2 quarters · filed 2021-11-09
-$69.84M
10-Q · filed 2021-11-09
-$1.71M
derived: sum of 4 quarters · filed 2022-03-03
2021-07-04$8.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
-$36.96M
10-Q · filed 2021-08-10
$31.18M
derived: sum of 3 quarters · filed 2022-03-03
$85.89M
derived: sum of 4 quarters · filed 2022-03-03
2021-04-04-$45.39M
10-Q · filed 2021-05-11
$22.75M
derived: sum of 2 quarters · filed 2022-03-03
$77.46M
derived: sum of 3 quarters · filed 2022-03-03
$133.24M
derived: sum of 4 quarters · filed 2022-03-03
2021-01-03$68.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$122.85M
derived: sum of 2 quarters · filed 2022-03-03
$178.62M
derived: sum of 3 quarters · filed 2022-03-03
$120.68M
10-K · filed 2022-03-03
2020-10-04$54.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
$110.49M
derived: sum of 2 quarters · filed 2020-11-10
$52.55M
10-Q · filed 2020-11-10
$84.55M
derived: sum of 4 quarters · filed 2021-03-02
2020-07-05$55.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
-$2.17M
10-Q · filed 2020-08-11
$29.83M
derived: sum of 3 quarters · filed 2021-03-02
-$19.05M
derived: sum of 4 quarters · filed 2021-03-02
2020-04-05-$57.94M
10-Q · filed 2020-05-12
-$25.94M
derived: sum of 2 quarters · filed 2021-03-02
-$74.83M
derived: sum of 3 quarters · filed 2021-03-02
-$57.34M
derived: sum of 4 quarters · filed 2021-03-02
2019-12-29$32.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02
-$16.89M
derived: sum of 2 quarters · filed 2021-03-02
$598.00K
derived: sum of 3 quarters · filed 2021-03-02
-$18.28M
10-K · filed 2021-03-02
2019-09-29-$48.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$31.40M
derived: sum of 2 quarters · filed 2019-11-05
-$50.28M
10-Q · filed 2019-11-05
-$59.98M
derived: sum of 4 quarters · filed 2020-02-25
2019-06-30$17.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$1.40M
10-Q · filed 2019-08-06
-$11.10M
derived: sum of 3 quarters · filed 2020-02-25
-$20.18M
derived: sum of 4 quarters · filed 2020-02-25
2019-03-31-$18.88M
10-Q · filed 2019-05-07
-$28.58M
derived: sum of 2 quarters · filed 2020-02-25
-$37.66M
derived: sum of 3 quarters · filed 2020-02-25
-$106.42M
derived: sum of 4 quarters · filed 2020-02-25
2018-12-30-$9.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$18.78M
derived: sum of 2 quarters · filed 2020-02-25
-$87.53M
derived: sum of 3 quarters · filed 2020-02-25
-$67.48M
10-K · filed 2020-02-25
2018-09-30-$9.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$77.84M
derived: sum of 2 quarters · filed 2018-11-06
-$57.78M
10-Q · filed 2018-11-06
-$44.79M
derived: sum of 4 quarters · filed 2019-02-26
2018-07-01-$68.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
-$48.70M
10-Q · filed 2018-08-07
-$35.71M
derived: sum of 3 quarters · filed 2019-02-26
-$20.43M
derived: sum of 4 quarters · filed 2019-02-26
2018-04-01$20.06M
10-Q · filed 2018-05-08
$33.04M
derived: sum of 2 quarters · filed 2019-02-26
$48.32M
derived: sum of 3 quarters · filed 2019-02-26
$76.53M
derived: sum of 4 quarters · filed 2019-02-26
2017-12-31$12.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$28.27M
derived: sum of 2 quarters · filed 2019-02-26
$56.47M
derived: sum of 3 quarters · filed 2019-02-26
$66.74M
10-K · filed 2019-02-26
2017-10-01$15.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$43.48M
derived: sum of 2 quarters · filed 2017-11-07
$53.75M
10-Q · filed 2017-11-07
$26.21M
derived: sum of 4 quarters · filed 2018-02-27
2017-07-02$28.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$38.47M
10-Q · filed 2017-08-08
$10.93M
derived: sum of 3 quarters · filed 2018-02-27
2017-04-02$10.27M
10-Q · filed 2017-05-09
-$17.27M
derived: sum of 2 quarters · filed 2018-02-27
2017-01-01-$27.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-$28.48M
10-K · filed 2018-02-27
2016-10-02-$938.00K
10-Q · filed 2016-11-08
2016-01-03-$54.72M
10-K · filed 2017-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16